These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 6369777)

  • 1. [Ambulatory chemotherapy of hematosarcoma].
    Finogenova IA; Abdylbaev RA
    Vopr Onkol; 1984; 30(3):77-81. PubMed ID: 6369777
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Treatment of primary mediastinal large B-cell lymphomas].
    Schneider T; Tóth E; Molnár Z; Várady E; Deák B; Horváth A; Horváth GI; Eid H; Schneider K; Lovey J; Keresztes S; Esik O; Lengyel Z; Rosta A
    Orv Hetil; 2004 Dec; 145(50):2531-7. PubMed ID: 15662753
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Efficacy of rituximab-containing salvage regimens on relapsed or refractory B-cell non-Hodgkin's lymphoma].
    Huang HQ; Bu Q; Xia ZJ; Lin XB; Wang FH; Li YH; Peng YL; Pan ZH; Wang SS; Lin TY; Jiang WQ; Guan ZZ
    Ai Zheng; 2006 Apr; 25(4):486-9. PubMed ID: 16613686
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [CEOP regimen in the treatment for non-Hodgkin's lymphoma].
    Huang HQ; Lin XB; Pan ZH; Bu Q; Gao Y; Wang BF; Cai QQ; Xia ZJ; Xu RH; Jiang WQ; Guan ZZ
    Zhonghua Zhong Liu Za Zhi; 2007 May; 29(5):391-5. PubMed ID: 17892140
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Late phase II clinical study of amrubicin hydrochloride, a novel synthetic anthracycline derivative anticancer agent, for malignant lymphoma].
    Akutsu M; Kano Y; Ogawa M; Miura A; Hirano M; Masaoka T; Tatsumi N
    Gan To Kagaku Ryoho; 2001 Nov; 28(12):1867-76. PubMed ID: 11729479
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Treatment of high malignancy lymphoma with intensive short-term chemotherapy using the MACOP-B regimen].
    Delmer A; Bauduer F; Ruskoné-Fourmestraux A; Ajchenbaum-Cymbalista F; Delmas-Marsalet B; Rio B; Marie JP; Zittoun R
    Bull Cancer; 1993 Sep; 80(9):808-15. PubMed ID: 7515735
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Concurrent chemo-radiotherapy for localized refractory non-Hodgkin's lymphoma--report of two cases].
    Sugimoto T; Matano S; Nishijima H; Kakuta K; Inamura K; Okamura T; Munemoto S; Satoh S
    Gan To Kagaku Ryoho; 2007 Jan; 34(1):125-8. PubMed ID: 17220687
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Trichlortriethylamine (TS-160 Spofa) in combination chemotherapy of malignant lymphomas.
    Klener P; Donner L
    Neoplasma; 1975; 22(1):55-62. PubMed ID: 1097949
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Safety and efficacy of a continuous infusion, patient controlled anti-emetic pump to facilitate outpatient administration of high-dose chemotherapy.
    Dix S; Cord M; Howard S; Coon J; Belt R; Geller R
    Bone Marrow Transplant; 1999 Sep; 24(5):561-6. PubMed ID: 10482943
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Comparison between R-CHOP regimen and CHOP regimen in treating naive diffuse large B-cell lymphoma in China--a multi-center randomized trail].
    Lin TY; Zhang HY; Huang Y; Guan ZZ; Shen T; Shi YK; Zhu J; Ke XY; Wang HQ; Shen ZX; Yu SY; Liu T; Shi XL
    Ai Zheng; 2005 Dec; 24(12):1421-6. PubMed ID: 16351785
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Prognosis and treatment strategies of primary B-cell and NK/T-cell nasopharyngeal non-Hodgkin's lymphoma at early stage].
    Zou GR; Zhang YJ; Xie FY; Zheng W; Li HX; Xia YF; Lin TY; Lu TX
    Ai Zheng; 2006 Dec; 25(12):1543-9. PubMed ID: 17166383
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Evaluation of the CCNU-COP regimen for primary refractory and recurrent non-Hodgkin's lymphoma].
    Gershanovich ML; Akimov MA
    Vopr Onkol; 1999; 45(4):438-40. PubMed ID: 10532107
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [CAMBO-VIP for advanced diffuse large cell lymphoma (LSG classification)--a long-term follow-up study].
    Okamoto M; Maruyama F; Tsuzuki M; Nomura T; Miyazaki H; Wakita M; Kojima H; Sobue R; Matsui T; Ino T
    Gan To Kagaku Ryoho; 1994 Jan; 21(1):67-73. PubMed ID: 7507314
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [MTX-HOPE (methotrexate, hydrocortisone, vincristine, sobuzoxane, and etoposide) as a low-dose salvage chemotherapy for recurrent or refractory non-Hodgkin's lymphoma].
    Tsunoda S; Kobayashi H; Inoue K; Izumi T; Akutsu M; Katano S; Ueda T; Shirai T; Masuda Y; Ohmine K; Nagashima T; Ueda M; Takagi S; Muroi K; Ozawa K; Kano Y
    Gan To Kagaku Ryoho; 2007 Jun; 34(6):885-9. PubMed ID: 17565251
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Comparison of rituximab plus CHOP regimen and CHOP regimen alone for treatment of newly diagnosed patients with diffuse large B-cell lymphoma].
    Wu HJ; Zhang QY; Chen DF; Guan XJ; Zhang BL; Ma J
    Ai Zheng; 2005 Dec; 24(12):1498-502. PubMed ID: 16351800
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Primary mediastinal large B-cell lymphoma (PMLBCL): long-term results from a retrospective multicentre Italian experience in 138 patients treated with CHOP or MACOP-B/VACOP-B.
    Todeschini G; Secchi S; Morra E; Vitolo U; Orlandi E; Pasini F; Gallo E; Ambrosetti A; Tecchio C; Tarella C; Gabbas A; Gallamini A; Gargantini L; Pizzuti M; Fioritoni G; Gottin L; Rossi G; Lazzarino M; Menestrina F; Paulli M; Palestro M; Cabras MG; Di Vito F; Pizzolo G
    Br J Cancer; 2004 Jan; 90(2):372-6. PubMed ID: 14735179
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Results of combined chemotherapy of lymphosarcoma with cyclophosphamide, vincristine and prednisolone].
    Abdyldaev RA; Kruglova GV
    Vopr Onkol; 1983; 29(4):83-5. PubMed ID: 6687966
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term follow-up of patients with intermediate or high-grade non-Hodgkin lymphoma treated with a combination of cyclophosphamide, epirubicin, vincristine, and prednisone.
    Rossini F; Terruzzi E; Perego D; Miccolis I; Rivolta F; Manca E; Pogliani EM
    Cancer; 2004 Jan; 100(2):350-5. PubMed ID: 14716771
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modified MACOP-B chemotherapy for intermediate and high grade non Hodgkins lymphomas.
    Gopal R; Nair R; Saikia TK; Soman CS; Dinshaw KA; Advani SH
    J Assoc Physicians India; 1994 Oct; 42(10):781-4. PubMed ID: 7533151
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [A study of toxicities and complications observed in alternating non-cross-resistant chemotherapy (CAMBO-VIP) for non-Hodgkin's lymphoma].
    Maruyama F; Ezaki K; Okamoto M; Miyazaki H; Wakita M; Nomura T; Tsuzuki M; Kojima H; Sobue R; Matsui T
    Gan To Kagaku Ryoho; 1993 Jul; 20(9):1195-201. PubMed ID: 8333748
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.